|
VEGFR2 Kinase Inhibitor IV
KDR/Flk-1 Kinase Inhibitor IV, 3-(3-Thienyl)-6-(4-methoxyphenyl)pyrazolo[1,5-a]pyrimidine, Vascular Endothelial Growth FactorReceptor 2 Kinase Inhibitor IV, VEGFR Tyrosine Kinase Inhibitor XVIII, VEGFR1 Kinase Inhibitor II, VEGFR3 Kinase Inhibitor II, PDGFR Tyrosine Kinase Inhibitor IX
A 3,6-diaryl substituted pyrazolopyrimidine that acts as a potent, reversible, and ATP-competitive inhibitor of VEGFR-2 (KDR/Flk-1; IC50 = 19 nM). Displays ~2-fold greater selectivity for VEGFR-2 over PDGFRβ (IC50 = 34 nM) and 10-fold greater selectivity over VEGFR-1 (Flt-1) and VEGFR-3 (Flt-4; IC50 = 190 nM) tyrosine kinase activity. Does not inhibit FGFR-1 or Src kinase activity (IC50 > 1.9 µM). Shown to inhibit VEGF-stimulated mitogenesis in human umbilical vein endothelial cells (IC50 = 387 nM). Inhibits Flt3 phosphorylation in Flt3/Itd-BaF3 cells.
产品信息
Form Yellow solid
Primary Target VEGFR-2 KDR/Flk-1
Primary Target IC50 19 nM
Secondary target PDGFRb (IC50 = 34 nM)
Molar mass 307.4
Protect from Light 是的
Packaged under inert gas 是的
ATP Competitive 是的
Purity ≥95% by HPLC
Solubility DMSO
Chemical formula C17H13N3OS
CAS number 216661-57-3
商店和运输信息
Storage +2°C to +8°C
Ship Ambient Temperature Only
Standard Handling |